Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus has long been recognized as an important pathogen in human disease. Due to an increasing number of infections caused by methicillin-resistant S. aureus (MRSA) strains, therapy has become problematic. Therefore, prevention of staphylococcal infections has become more important. Carriage of S. aureus appears to play a key role in the epidemiology and pathogenesis of infection. The ecological niches of S. aureus are the anterior nares. In healthy subjects, over time, three patterns of carriage can be distinguished: about 20% of people are persistent carriers, 60% are intermittent carriers, and approximately 20% almost never carry S. aureus. The molecular basis of the carrier state remains to be elucidated. In patients who repeatedly puncture the skin (e.g., hemodialysis or continuous ambulatory peritoneal dialysis [CAPD] patients and intravenous drug addicts) and patients with human immunodeficiency virus (HIV) infection, increased carriage rates are found. Carriage has been identified as an important risk factor for infection in patients undergoing surgery, those on hemodialysis or CAPD, those with HIV infection and AIDS, those with intravascular devices, and those colonized with MRSA. Elimination of carriage has been found to reduce the infection rates in surgical patients and those on hemodialysis and CAPD. Elimination of carriage appears to be an attractive preventive strategy in patients at risk. Further studies are needed to optimize this strategy and to define the groups at risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“People who misuse drugs have a higher rate of nasal or skin colonization with S. aureus than the general population (2, 14).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“S. aureus nasal carriage, present in about 20% of the general population, has been identified as a risk factor for the subsequent development of community-acquired and nosocomial staphylococcal infections (14, 22).”
From Methicillin-Resistant Staphylococcus aureus Nasal Carriage among Injection Drug Users: Six Years Later (2008) · cites this paper as [14]
In the citing paper
“Carriage of S. aureus is a significant risk factor for nosocomial invasive infections by S. aureus (Kluytmans et al., 1997).”
From Nasal Microenvironments and Interspecific Interactions Influence Nasal Microbiota Complexity and S. aureus Carriage (2013) · cites this paper as Kluytmans et al., 1997
Citations
Cites
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286 · cited 1×
“In 1992, resistance had increased to nearly 8% (66).”
BackgroundThe Spectrum of Vasculitis: Clinical, Pathologic, Immunologic, and Therapeutic Considerations
FAUCI, A. S., HAYNES, B. F., & KATZ, P. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-660 · Cited by 1,196 · cited 1×
“Wegener’s granulomatosis is a systemic disease characterized by necrotizing granulomatous inflammation of the upper and lower respiratory tract in combination with vasculitis and focal necrotizing crescentic glomerulonephritis (52).”
BackgroundMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109 · cited 1×
“aureus is the second most prevalent organism causing intravascular device-associated bacteremia (111, 165).”
BackgroundMethicillin-ResistantStaphylococcus aureus in Europe
Voss, A., Milatovic, D., Wallrauch-Schwarz, C., Rosdahl, V. T., & Braveny, I. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026127 · Cited by 801
Stegeman, C. A., Tervaert, J. W. C., Sluiter, W. J., Manson, W. L., de Jong, P. E., & Kallenberg, C. G. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00003 · Cited by 729
Prevention and Control of Nosocomial Infections.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-5-791_4 · Cited by 719
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Noble, W. C., Virani, Z., & Cree, R. G. A. (1992) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1992.tb05089.x · Cited by 627
Cited by
Items 201–300 of 1,002
Methicillin-Resistant Staphylococcus aureus: A Food-Borne Pathogen?
Wendlandt, S., Schwarz, Š., & Silley, P. (2012) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182653 · Cited by 151
Struelens, M. J., Hawkey, P. M., French, G. L., Witte, W., & Tacconelli, E. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02698.x · Cited by 148
“aureus preoperative topical decolonization and/or perioperative prophylaxis [7].”
Wertheim, H. F. L., Vos, M. D., Ott, A., Voß, A., Kluytmans, J. A. J. W., Vandenbroucke‐Grauls, C. M. J. E., Meester, M. H. M., van Keulen, P. H. J., & Verbrugh, H. A. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-6-200403160-00007 · Cited by 146
“aureus infections was far lower than that estimated a priori (10).”
BackgroundSelf-citationWertheim, H. F. L., Verveer, J., Boelens, H. A. M., van Belkum, A., Verbrugh, H. A., & Vos, M. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1465-1467.2005 · Cited by 146
“In humans, the nose is the primary reservoir of S. aureus (6, 7). Approximately 30% of the healthy population carry S. aureus in the nose, which is an important risk factor for S. aureus infections ( 6 ).”
BackgroundSelf-citationNAKAMURA, M. M., ROHLING, K. L., SHASHATY, M., LU, H., TANG, Y.-W., & EDWARDS, K. M. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00006 · Cited by 130
“18, 20, 21 Studies have found that nasal colonization with MRSA poses an increased risk of infection over that seen with MSSA carriage.(18) Additionally many cases have been documented of healthy carriers transmitting staphylococci to others with resulting infection.”
BackgroundChoi, S. J., Kim, M.-H., Jeon, J., Kim, O. Y., Choi, Y., Seo, J., Hong, S., Lee, W. H., Jeon, S. G., Gho, Y. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136021 · Cited by 143
Prince, T., McBain, A. J., & O’Neill, C. A. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.00595-12 · Cited by 142
“tent carriers, while 20% of people may be stably colonized (26).”
BackgroundImmunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
Lee, L., Samardzic, K., Wallach, M. G., Frumkin, L. R., & Mochly‐Rosen, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696003 · Cited by 145
Highly bacterial resistant silver nanoparticles: synthesis and antibacterial activities
Chudasama, B., Vala, A. K., Andhariya, N., Mehta, R. V., & Upadhyay, R. V. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-009-9845-1 · Cited by 140
“It is still one of the five most common causes of noscomial infections often causing postsurgical wound infections (Kluytmans et al. 1997).”
BackgroundShorr, A. F. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725090-00004 · Cited by 140
“groups of patients (including intravenous drug users, patients with HIV infection or insulin-dependent In addition to the burden on healthcare providers, diabetes mellitus and those requiring dialysis) more MRSA infections can have wider economic effects frequently affected.[14] that involve indirect costs to the pati…”
BackgroundEpidemiology of Staphylococcus aureus Nasal Carriage Patterns in the Community
Mehraj, J., Witte, W., Akmatov, M. K., Layer, F., Werner, G., & Krause, G. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_497 · Cited by 139
Large-Scale Identification of Genes Required for Full Virulence of Staphylococcus aureus
Benton, B. M., Zhang, J. P., Bond, S., Pope, C., Christian, T., Lee, L., Winterberg, K. M., Schmid, M. B., & Buysse, J. M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.24.8478-8489.2004 · Cited by 113
“Approximately 20% of individuals are persistently colonized, and another 60% of the population is colonized intermittently on the mucosal surface of the anterior nares (32).”
BackgroundMethicillin‐resistant Staphylococcus aureus infections in 11 dogs
Tomlin, J., Pead, M. J., Lloyd, D. H., Howell, S. A., Hartmann, F. A., Jackson, H. A., & Muir, P. (1999) · Veterinary Record · doi:10.1136/vr.144.3.60 · Cited by 139
Development and Characterization of a Staphylococcus aureus Nasal Colonization Model in Mice
Kiser, K. B., Cantey-Kiser, J. M., & Lee, J. C. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5001-5006.1999 · Cited by 125
“aureus colonization of the nares is asymptomatic, nasal carriage is a risk factor for subsequent infection, particularly in surgical patients, intensivecare-unit patients, patients with intravascular devices, and human immunodeficiency virus-positive individuals (16).”
BackgroundInfluentialHigh Rate of Transfer of Staphylococcus aureus from Parental Skin to Infant Gut Flora
Lindberg, E., Adlerberth, I., Hesselmar, B., Saalman, R., Strannegård, I.-L., Åberg, N., & Wold, A. E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.530-534.2004 · Cited by 108
“aureus at other body sites as well (14, 20, 23).”
BackgroundResultRelationship Between Maternal and Neonatal Staphylococcus aureus Colonization
Jimenez‐Truque, N., Tedeschi, S. K., Saye, E. J., McKenna, B. D., Langdon, W., Wright, J. P., Alsentzer, A., Arnold, S. R., Saville, B. R., Wang, W., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2308 · Cited by 137
Discovery of Medically Significant Lantibiotics
Piper, C., Cotter, P., Ross, R., & Hill, C. (2009) · Current Drug Discovery Technologies · doi:10.2174/157016309787581075 · Cited by 116
“aureus by healthy individuals with a greater likelihood of developing severe staphylococcal associated diseases [208-210].”
BackgroundStaphylococcus aureus Colonization of the Human Nose and Interaction with Other Microbiome Members
Laux, C., Peschel, A., & Krismer, B. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0029-2018 · Cited by 136
“Although nasal colonization by S. aureus is asymptomatic, it increases the risk of invasive infections, especially in immunocompromised and hospitalized patients (4, 13).”
BackgroundInfluentialEllis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01086-06 · Cited by 129
“infection with the endogenous strain (12, 28, 45, 47, 49, 51, 52).”
BackgroundInfluentialThe epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden
Jacobsson, G., Dashti, S., Wahlberg, T., & Andersson, R. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540600810026 · Cited by 115
“Elimination of nasal carriage of Staphylococcus aureus in haemodialysis patients with topical antibiotics reduces infection rate but carries a risk for development of resistance [23].”
BackgroundStaphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy
Kôyama, A., Sharmin, S., Sakurai, H., Shimizu, Y., Hirayama, K., Usui, J., Nagata, M., Yoh, K., Yamagata, K., Muro, K., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00714.x · Cited by 134
(EFSA), E. F. S. A. (2009) · EFSA Journal · doi:10.2903/j.efsa.2009.993 · Cited by 134
Staphylococcal Proteases Aid in Evasion of the Human Complement System
Jusko, M., Potempa, J., Kantyka, T., Bielecka, E., Miller, H. K., Kalinska, M., Dubin, G., Garred, P., Shaw, L. N., & Blom, A. M. (2014) · Journal of Innate Immunity · doi:10.1159/000351458 · Cited by 109
Askarian, M., Zeinalzadeh, A., Japoni, A., Alborzi, A., & Memish, Z. A. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.11.026 · Cited by 132
Distribution of virulence genes ofStaphylococcus aureusisolated from stable nasal carriers
Nashev, D., Toshkova, K., Salasia, S. I. O., Hassan, A. A., Lämmler, C., & Zschöck, M. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.01.032 · Cited by 132
“org/ D ow nladed from designated as persistent or stable carriers, and 30–70% intermittently, designated as intermittent nasal carriers [1].”
BackgroundInfluentialVotintseva, A. A., Fung, R., Miller, R. R., Knox, K., Godwin, H., Wyllie, D. H., Bowden, R. J., Crook, D. W., & Walker, A. S. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-63 · Cited by 131
“Background Staphylococcus aureus is a commensal organism that colonizes nasal mucosa in 25-30% of the healthy human population [1-6] and is responsible for a wide range of human diseases including serious nosocomial infections.”
BackgroundSquier, C. L., Rihs, J. D., Risa, K. J., Sagnimeni, A., Wagener, M. M., Stout, J. E., Muder, R. R., & Singh, N. (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502095 · Cited by 131
Donegan, N. P., & Cheung, A. L. (2009) · Journal of Bacteriology · doi:10.1128/jb.01713-08 · Cited by 131
“, the nares of healthy individuals) (27) and abiotic environments (e.”
BackgroundShiomori, T., Yoshida, S.-I., Miyamoto, H., & Makishima, K. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104256 · Cited by 131
Zacharioudakis, I. M., Zervou, F. N., Ziakas, P. D., & Mylonakis, E. E. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013091028 · Cited by 130
Goerge, T., Lorenz, M. B., van Alen, S., Hübner, N., Becker, K., & Köck, R. (2015) · Veterinary Microbiology · doi:10.1016/j.vetmic.2015.10.027 · Cited by 129
Bacteriophage-Derived Peptidase CHAPK Eliminates and Prevents Staphylococcal Biofilms
Fenton, M., Keary, R., McAuliffe, O. E., Ross, R. P., O’Mahony, J., & Coffey, A. (2013) · International Journal of Microbiology · doi:10.1155/2013/625341 · Cited by 132
“Infection can oen originate from commensal �ora, especially in veterinary and hospital settings, as is the case with both bovine and human mastitis [64, 65].”
BackgroundPlouin‐Gaudon, I., Clément, S., Huggler, E., Chaponnier, C., François, P., Lew, D., Schrenzel, J., Vaudaux, P. E., & Lacroix, J. S. (2006) · PubMed · Cited by 128
Molecular techniques for MRSA typing: current issues and perspectives
Trindade, P. D. A., McCulloch, J. A., Oliveira, G. A., & Mamizuka, E. M. (2003) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702003000100005 · Cited by 127
“Serious staphylococcal infections can frequently occur in inpatients and may lead to dire consequences, especially for therapy with antimicrobial agents [1].”
BackgroundAntimicrobial Activity of Host-Derived Lipids
Fischer, C. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020075 · Cited by 126
“aureus is relatively stable within individuals - especially in the nose [124], which is also rich in antimicrobial peptides [125]”
BackgroundMethicillin-resistantStaphylococcus aureus(MRSA): Colonisation and pre-operative screening
Goyal, N., Miller, A., Tripathi, M. S., & Parvizi, J. (2013) · The Bone & Joint Journal · doi:10.1302/0301-620x.95b1.27973 · Cited by 125
Sporer, S. M., Rogers, T. J., & Abella, L. (2016) · The Journal of Arthroplasty · doi:10.1016/j.arth.2016.05.019 · Cited by 125
“44 Previous authors have shown that many of the current orthopaedic SSI are secondary to strains of 45 Staphylococcus aureus which originated from the patient and that nasal colonization of 46 Staphylococcus aureus is one of the most important risk factors for the development of a surgical 47 site infection.(4) The in…”
Exclusive Staphylococcus aureus Throat Carriage: At-Risk Populations
Mertz, D., Frei, R., Periat, N., Zimmerli, M., Battegay, M., Flückiger, U., & Widmer, A. F. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.536 · Cited by 124
Quave, C. L., Lyles, J. T., Kavanaugh, J. S., Nelson, K., Parlet, C. P., Crosby, H. A., Heilmann, K. P., & Horswill, A. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136486 · Cited by 126
“It colonizes the nasal passages of approximately 30% of the healthy adult population, which translates to 79 million colonized people in the US alone [8].”
BackgroundStaphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen
Park, S.-Y., & Ronholm, J. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00182-20 · Cited by 124
“aureus colonization in humans is not necessarily associated with disease; however, skin trauma, such as an injury or a surgical procedure, can result in an opportunistic skin or wound infection (7).”
BackgroundInfluentialLevy, P., Ollivier, M. P., Drancourt, M., Raoult, D., & Argenson, J. (2013) · Orthopaedics & Traumatology Surgery & Research · doi:10.1016/j.otsr.2013.03.030 · Cited by 124
Paule, S. M., Hacek, D. M., Kufner, B., Truchon, K., Thomson, R. B., Kaul, K. L., Robicsek, A. A., & Peterson, L. R. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00670-07 · Cited by 124
“aureus serves as a source for the spread of the organism to other parts of the body and antedates bacteremia as well as nonbacteremic infection (11, 28), it is most likely that these patients truly harbored the microbe, even if it was not cultivatable in the nares at the time of our sampling; perhaps this represents a…”
BackgroundWernitz, M. H., Swidsinski, S., Weist, K., Sohr, D., Witte, W., Franke, K.-P., Roloff, D., Rüden, H., & Veit, S. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01152.x · Cited by 123
Bowman, L., Zeden, M. S., Schuster, C. F., Kaever, V., & Gründling, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.747709 · Cited by 114
“This microorganism has also developed resistance to many antibiotics, which has reduced the number of therapeutic choices available (3, 4).”
BackgroundNewstead, L. L., Varjonen, K., Nuttall, T. J., & Paterson, G. K. (2020) · Antibiotics · doi:10.3390/antibiotics9020040 · Cited by 122
Dynamics and Determinants of Staphylococcus aureus Carriage in Infancy: the Generation R Study
Lebon, A., Labout, J. A. M., Verbrugh, H. A., Jaddoe, V. W. V., Hofman, A., van Wamel, W., Moll, H. A., & van Belkum, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00641-08 · Cited by 95
“This rather high frequency of 63% in the infants might also be explained by recolonization with the strain from the mother or other family members, who might be persistent carriers in 20% of the cases (10, 19).”
BackgroundSelf-citationFood Safety – Problems and Solutions
Uçar, A., Yılmaz, M. V., & Çakiroğlu, F. P. (2016) · InTech eBooks · doi:10.5772/63176 · Cited by 121
Munckhof, W., Nimmo, G. R., Schooneveldt, J. M., Schlebusch, S., Stephens, A. J., Williams, G. M., Huygens, F., & Giffard, P. M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02652.x · Cited by 121
Bacterial conjunctivitis: A review for internists
Tarabishy, A. B., & Jeng, B. H. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.7.507 · Cited by 121
Metagenomics of the Human Body
Nelson, K. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3 · Cited by 121
Prevention of Recurrent Staphylococcal Skin Infections
Creech, C. B., Al-Zubeidi, D. N., & Fritz, S. A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.05.007 · Cited by 121
Structure–function relationships in the tryptophan‐rich, antimicrobial peptide indolicidin
Neumann‐Staubitz, P., Peschel, A., Nieuwenhuizen, W. F., Otto, M. J., Götz, F., Jung, G., & Jack, R. W. (2001) · Journal of Peptide Science · doi:10.1002/psc.351 · Cited by 120
Lozano, C., Gómez-Sanz, E., Benito, D., Aspíroz, C., Zarazaga, M., & Torres, C. (2011) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2011.02.004 · Cited by 119
Indole and 7-benzyloxyindole attenuate the virulence of Staphylococcus aureus
Lee, J., Cho, H. S., Kim, Y., Kim, J., Banskota, S., Cho, M. H., & Lee, J. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4674-z · Cited by 119
“aureus is on the skin and in the nasal cavity (Kluytmans et al. 1997), some pathogenic S.”
BackgroundCommunity‐Associated Methicillin‐Resistant Staphylococcus aureus and HIV: Intersecting Epidemics
Popovich, K. J., Weinstein, R. A., Aroutcheva, A., Rice, T., & Hota, B. (2010) · Clinical Infectious Diseases · doi:10.1086/651076 · Cited by 108
“980 • CID 2010:50 (1 April) • Popovich et al reus colonization [18, 19] and infection [20], in particular SSTIs [21, 22].”
BackgroundStaphylococcus aureus Infections in Injection Drug Users: Risk Factors and Prevention Strategies
Bassetti, S., & Battegay, M. (2004) · Infection · doi:10.1007/s15010-004-3106-0 · Cited by 118
“Examples include anatomic abnormalities of the nose, certain leukocyte antigens, immunological status, viral infections of the upper respiratory tract, age, ethnicity, hospitalization [37], hormonal status in women [41], previous use of antibiotics [41], use of nasal steroid sprays [42], and the presence of atopic der…”
Aila, N. A. E., Laham, N. A., & Ayesh, B. M. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-016-2139-1 · Cited by 118
“aureus appears to play a key role in the epidemiology and pathogenesis of infection [3].”
BackgroundLearning from bacterial competition in the host to develop antimicrobials
Raffatellu, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0145-0 · Cited by 121
Determinants of Phage Host Range in Staphylococcus Species
Moller, A. G., Lindsay, J. A., & Read, T. D. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.00209-19 · Cited by 100
“aureus is carried by between 20% (persistently) and 60% (intermittently) of the human population (1), primarily on the skin and upper respiratory tract.”
BackgroundStaphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin
Peschel, A., & Collins, L. V. (2001) · Peptides · doi:10.1016/s0196-9781(01)00500-9 · Cited by 119
Costa, A.-M., Kay, I., & Palladino, S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2004.08.014 · Cited by 117
Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance
Taft, D. H., Liu, J., Maldonado-Gomez, M. X., Akre, S., Huda, M. N., Ahmad, S. M., Stephensen, C. B., & Mills, D. A. (2018) · mSphere · doi:10.1128/msphere.00441-18 · Cited by 107
“The carriage of AMR organisms carries risks for human health; harboring AMR organisms correlates with an increased risk of severe infection and death (24–26).”
Staphylococcal superantigens: do they play a role in sepsis?
Holtfreter, S., & Bröker, B. M. (2005) · PubMed · Cited by 117
Longitudinal Study on Methicillin-Resistant Staphylococcus pseudintermedius in Households
Laarhoven, L. M., de Heus, P., van Luijn, J., Duim, B., Wagenaar, J. A., & van Duijkeren, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027788 · Cited by 116
“aureus several factors are known to influence the rate of nasal carriage in humans [25].”
BackgroundRisk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections
Öztoprak, N., ÇEVİK, M. A., Akıncı, E., Korkmaz, M., Erbay, A., Eren, S., Balaban, N., & Bodur, H. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.07.005 · Cited by 116
How does Staphylococcus aureus escape the bloodstream?
Edwards, A. M., & Massey, R. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.12.005 · Cited by 119
Massey, R. C., Horsburgh, M. J., Lina, G., Höök, M., & Recker, M. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1551 · Cited by 115
Anderson, A. S., Miller, A. A., Donald, R. G. K., Scully, I. L., Nanra, J. S., Cooper, D., & Jansen, K. U. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21872 · Cited by 116
Weiser, M. C., & Moucha, C. S. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.01114 · Cited by 114
Host- and microbe determinants that may influence the success of S. aureus colonization
Johannessen, M., Sollid, J. E., & Hanssen, A.-M. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00056 · Cited by 114
“The persistent carriage rate varies depending on age, gender, serum glucose level, smoking, oral contraceptive use, dialysis, and/or drug addiction (Kluytmans et al., 1997; Choi et al., 2006; Olsen et al., 2009; van Belkum, 2011).”
InfluentialSecreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureus
Chen, C., Krishnan, V., Macon, K. J., Manne, K., Narayana, S. V. L., & Schneewind, O. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502039 · Cited by 114
“aureus colonization are the humannares (2).”
Ganesh, V. K., Barbu, E. M., Deivanayagam, C. C. S., Le, B., Anderson, A. S., Matsuka, Y. V., Lin, S. L., Foster, T. J., Narayana, S. V. L., & Höök, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217414 · Cited by 92
Lee, B. Y., Bartsch, S. M., Wong, K. F., Singh, A., Avery, T. R., Kim, D. S., Brown, S. T., Murphy, C. R., Yilmaz, S. L., Potter, M. A., et al. (2013) · Medical Care · doi:10.1097/mlr.0b013e3182836dc2 · Cited by 111
“MRSA-positive patients could lose MRSA carriage over time(30–33); one-third had indefinite carriage(34) and the remainder experienced a linear carriage loss with a half-life of six months(30, 33).”
BackgroundZeden, M. S., Schuster, C. F., Bowman, L., Zhong, Q., Williams, H. D., & Gründling, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.818716 · Cited by 108
“Then, 4.8 μl of glycine-1-14C (Hartmann Analytic) or D/L-alanine-(1)-14C (Hartmann Analytic) was added to the remaining 350 μl sample yielding a final concentration of 25 μM radiolabeled compound.”
BackgroundMethodInfluentialMinich, J. J., Petrus, S., Michael, J. D., Michael, T. P., Knight, R. D., & Allen, E. E. (2020) · mSphere · doi:10.1128/msphere.00401-20 · Cited by 111
“Examples in other vertebrates of widespread prevalence of opportunistic pathogens include 20 to 80% carriage rates of Staphylococcus aureus in humans (57).”
Osteomyelitis: a current challenge
Jorge, L. S., Chueire, A. G., & Rossit, A. R. B. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70063-5 · Cited by 109
“This bacterium is a member of the normal fl ora of the human nasal cavity with, approximately, 20% of people within a population colonized by these microorganisms in a persistent manner, while another 60% are transiently colonized.(21) Due to its high virulence, S.”
BackgroundColonizing opportunistic pathogens (COPs): The beasts in all of us
Price, L. B., Hungate, B. A., Koch, B. J., Davis, G. S., & Liu, C. M. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006369 · Cited by 95
Halablab, M. A., Hijazi, S. M., Fawzi, M. A., & Araj, G. F. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809991233 · Cited by 109
Transmission through air as a possible route of exposure for MRSA
Bos, M. E. H., Verstappen, K. M. H. W., van Cleef, B. A. G. L., Dohmen, W., Dorado-García, A., Graveland, H., Duim, B., Wagenaar, J. A., Kluytmans, J. A. J. W., & Heederik, D. J. J. (2014) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2014.85 · Cited by 109
Self-citationExpansion of Microbial Forensics
Schmedes, S. E., Sajantila, A., & Budowle, B. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00046-16 · Cited by 109
“Shared drug paraphernalia can be an avenue for bacterial transmission (64), in which colonization can be transient or permanent (65).”
BackgroundBacterial chondronecrosis with osteomyelitis ('femoral head necrosis') of broiler chickens: A review
McNamee, P. T., & Smyth, J. A. (2000) · Avian Pathology · doi:10.1080/030794500750047243 · Cited by 109
Staphylococcal Vaccines and Immunotherapies
Schaffer, A. C., & Lee, J. C. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.005 · Cited by 108
“The primary niche for S aureus in people is the nares, and nasal carriage is a documented risk factor for staphylococcal infection.(84,85) The source of approximately”
BackgroundShooting up: the interface of microbial infections and drug abuse
Kaushik, K. S., Kapila, K., & Praharaj, A. K. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.027540-0 · Cited by 108
“While the exact cause is unknown, repeated damage to the nasal epithelium by drug inhalation or skin damage by drug injection might play a role (Kluytmans et al., 1997; Kirmani et al., 1980).”
BackgroundExposure to TiO2 nanoparticles increases Staphylococcus aureus infection of HeLa cells
Xu, Y. S., Wei, M., Ou‐Yang, H. D., Walker, S. G., Wang, H.-Z., Gordon, C. R., Guterman, S., Zawacki, E., Applebaum, E., Brink, P. R., et al. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0184-y · Cited by 109
“The bacteria resides in the anterior nares of 20–30 % of humans [40, 41] and, besides being resistant to numerous antibiotics, is also able to evade host immune system [42–44].”
BackgroundMishra, A. K., Yadav, P., & Mishra, A. (2016) · The Open Microbiology Journal · doi:10.2174/1874285801610010150 · Cited by 107
“The outbreak of SSSS may be correlated with such carriers [16].”
A community-based study on nasal carriage of Staphylococcus aureus.
Chatterjee, S. S., Ray, P., Aggarwal, A. K., Das, A., & Sharma, M. (2009) · PubMed · Cited by 107
Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine
Tsai, C., Caldera, J. R., Hajam, I. A., Chiang, A. W. T., Tsai, C.-H., Li, H., Lázaro-Díez, M., Gonzalez, C., Trieu, D., Martins, G. A., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.06.006 · Cited by 107
STUDY OF METHICILLIN RESISTANT S. AUREUS (MRSA) ISOLATES FROM HIGH RISK PATIENTS
Vidhani, S., Mehndiratta, P. L., & Mathur, M. (2001) · Indian Journal of Medical Microbiology · doi:10.1016/s0255-0857(21)03365-x · Cited by 107
Rhinovirus Infections in the Upper Airway
Winther, B. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201006-039rn · Cited by 107
Fritz, S. A., Garbutt, J., Elward, A., Shannon, W., & Storch, G. A. (2008) · Pediatrics · doi:10.1542/peds.2007-2104 · Cited by 99
Campillo, B., Dupeyron, C., & Richardet, J. P. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801006288 · Cited by 107
“which the organism can be isolated [18].”
Verhulst, N. O., Takken, W., Dicke, M., Schraa, G., & Smallegange, R. C. (2010) · FEMS Microbiology Ecology · doi:10.1111/j.1574-6941.2010.00908.x · Cited by 94
Foletti, D. L., Strop, P., Shaughnessy, L., Hasa-Moreno, A., Casas, M. G., Russell, M., Bee, C., Wu, S., Pham, A. T., Zeng, Z., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.008 · Cited by 107
Emonts, M., Uitterlinden, A. G., Nouwen, J. L., Kardys, I., de Maat, M. P. M., Melles∗, D. C., Witteman, J. C. M., de Jong, P. T. V. M., Verbrugh, H. A., Hofman, A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/533501 · Cited by 106
“mately 1 out of 4 to 5 individuals [3–5].”
Self-citationCourville, X. F., Tomek, I. M., Kirkland, K. B., Birhle, M., Kantor, S. R., & Finlayson, S. R. G. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/663704 · Cited by 105
Detailed Contact Data and the Dissemination of Staphylococcus aureus in Hospitals
Obadia, T., Silhol, R., Opatowski, L., Temime, L., Legrand, J., Thiébaut, A. C. M., Herrmann, J., Fleury, É., Guillemot, D., Boëlle, P., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004170 · Cited by 105
“aureus transmission is also relevant for hospital hygiene, because its carriage increases the risk of healthcare-associated infections.[10] In our study, S.”
Investigation of Physicochemical Properties of Plasma Activated Water and its Bactericidal Efficacy
Rathore, V., Patel, D., Butani, S., & Nema, S. K. (2021) · Plasma Chemistry and Plasma Processing · doi:10.1007/s11090-021-10161-y · Cited by 104
Rongpharpi, S. R., Hazarika, N. K., & Kalita, H. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/4320.2741 · Cited by 104
“[2] Kluytmans J, van Belkum A, Verbrugh H.”
BackgroundPhagocytosis and Killing of Staphylococcus aureus by Human Neutrophils
Lu, T., Porter, A. R., Kennedy, A. D., Kobayashi, S. D., & DeLeo, F. R. (2014) · Journal of Innate Immunity · doi:10.1159/000360478 · Cited by 83
Sangvik, M., Olsen, R. S., Olsen, K. S., Simonsen, G. S., Furberg, A., & Ericson, J. U. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05290-11 · Cited by 103
“Within a healthy adult population, 20% are persistent nasal carriers, 30% intermittent carriers, and 50% noncarriers (7, 12, 14, 35).”
Background
Metadata
- Authors
- Kluytmans, J., van Belkum, A., & Verbrugh, H.
- Affiliations
- Ignatius Hospital (NL)
- Ignatius Hospital Breda, The Netherlands.
- ORCID
- Kluytmans, J
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1997-07
- Volume
- 10
- Issue
- 3
- Pages
- 505-520
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC172932
- OpenAlex
- W2111113492
- Cited by
- 2,595
- References
- 217
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 77 · 2023: 73 · 2022: 103 · 2021: 92 · 2020: 99 · 2019: 126 · 2018: 116 · 2017: 152 · 2016: 166 · 2015: 137 · 2014: 162 · 2013: 179 · 2012: 134
- FWCI
- 14.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Otolaryngology and Infectious Diseases
- Keywords
- Staphylococcus aureus, nasal carriage, methicillin-resistant Staphylococcus aureus, persistent carriage, infection risk factors, hemodialysis, continuous ambulatory peritoneal dialysis, people who inject drugs, HIV infection, surgical patients, intravascular devices, infection control
- MeSH terms
- Bacterial Adhesion, Carrier State, Endothelium, Endothelium, Corneal, Epithelium, Renal Dialysis, Humans, Peritoneal Dialysis, Continuous Ambulatory, Risk Factors, Staphylococcal Infections, Staphylococcus aureus, Surgical Wound Infection, HIV Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.